188 related articles for article (PubMed ID: 22846595)
1. A comparison of liquid-based cytology with conventional cytology in cervical cancer screening.
Akamatsu S; Kodama S; Himeji Y; Ikuta N; Shimagaki N
Acta Cytol; 2012; 56(4):370-4. PubMed ID: 22846595
[TBL] [Abstract][Full Text] [Related]
2. Performance and cost analysis of Siriraj liquid-based cytology: a direct-to-vial study.
Laiwejpithaya S; Benjapibal M; Laiwejpithaya S; Wongtiraporn W; Sangkarat S; Rattanachaiyanont M
Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):201-5. PubMed ID: 19747757
[TBL] [Abstract][Full Text] [Related]
3. Comparison of ThinPrep and SurePath liquid-based cytology and subsequent human papillomavirus DNA testing in China.
Zhao FH; Hu SY; Bian JJ; Liu B; Peck RB; Bao YP; Pan QJ; Frappart L; Sellors J; Qiao YL
Cancer Cytopathol; 2011 Dec; 119(6):387-94. PubMed ID: 21774094
[TBL] [Abstract][Full Text] [Related]
4. Comparison between Siriraj liquid-based and conventional cytology for detection of abnormal cervicovaginal smears: a split-sample study.
Laiwejpithaya S; Rattanachaiyanont M; Benjapibal M; Khuakoonratt N; Boriboonhirunsarn D; Laiwejpithaya S; Sangkarat S; Wongtiraporn W
Asian Pac J Cancer Prev; 2008; 9(4):575-80. PubMed ID: 19256741
[TBL] [Abstract][Full Text] [Related]
5. Causes and relevance of unsatisfactory and satisfactory but limited smears of liquid-based compared with conventional cervical cytology.
Siebers AG; Klinkhamer PJ; Vedder JE; Arbyn M; Bulten J
Arch Pathol Lab Med; 2012 Jan; 136(1):76-83. PubMed ID: 22208490
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).
Saraiya M; Irwin KL; Carlin L; Chen X; Jain N; Benard V; Montano DE
Cancer; 2007 Sep; 110(5):1024-32. PubMed ID: 17628488
[TBL] [Abstract][Full Text] [Related]
7. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
[TBL] [Abstract][Full Text] [Related]
8. Liquid-based cytology test use by office-based physicians: United States, 2006-2007.
Hing E; Saraiya M; Roland KB
Natl Health Stat Report; 2011 Jun; (40):1-6. PubMed ID: 21692417
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of conventional PAP smear with liquid based cytology method (LBC)].
Tsonev A; Ivanov S; Kovachev E
Akush Ginekol (Sofiia); 2012; 51(7):20-4. PubMed ID: 23610913
[TBL] [Abstract][Full Text] [Related]
10. A comparison of liquid-based and conventional cytology using data for cervical cancer screening from the Japan Cancer Society.
Ito K; Kimura R; Konishi H; Ozawa N; Yaegashi N; Ohashi Y; Suzuki M; Kakizoe T
Jpn J Clin Oncol; 2020 Feb; 50(2):138-144. PubMed ID: 31735963
[TBL] [Abstract][Full Text] [Related]
11. Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (the FASE study).
Monsonego J; Hudgens MG; Zerat L; Zerat JC; Syrjänen K; Smith JS
Gynecol Oncol; 2012 Apr; 125(1):175-80. PubMed ID: 22233689
[TBL] [Abstract][Full Text] [Related]
12. Direct-to-vial comparison of a new liquid-based cytology system, liqui-PREP versus the conventional pap smear.
Park J; Jung EH; Kim C; Choi YH
Diagn Cytopathol; 2007 Aug; 35(8):488-92. PubMed ID: 17636495
[TBL] [Abstract][Full Text] [Related]
13. Transformation zone sampling rate is a useful performance indicator for practitioners collecting cervical samples using SurePath liquid-based cytology system.
Narine N; Young W
Cytopathology; 2007 Aug; 18(4):220-4. PubMed ID: 17578516
[TBL] [Abstract][Full Text] [Related]
14. Results of the implementation of liquid-based cytology-SurePath in the Ontario screening program.
Colgan TJ; McLachlin CM; Cotterchio M; Howlett R; Seidenfeld AM; Mai VM
Cancer; 2004 Dec; 102(6):362-7. PubMed ID: 15481083
[TBL] [Abstract][Full Text] [Related]
15. The advantages of incorporating liquid-based cytology (TACAS™) in mass screening for cervical cancer.
Yokoyama Y; Futagami M; Watanabe J; Sakuraba A; Nagasawa K; Maruyama H; Sato S
Hum Cell; 2016 Apr; 29(2):83-90. PubMed ID: 26739336
[TBL] [Abstract][Full Text] [Related]
16. [Cervical cancer screening].
Aoki D; Saito E; Tominaga E
Gan To Kagaku Ryoho; 2012 Jan; 39(1):23-6. PubMed ID: 22241349
[TBL] [Abstract][Full Text] [Related]
17. Outcomes in cervical screening using various cytology technologies: what's age got to do with it?
Barken SS; Rebolj M; Lynge E; Junge J; Rygaard C
Eur J Cancer Prev; 2013 Jul; 22(4):367-73. PubMed ID: 22976387
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Unsatisfactory Rates and Detection of Abnormal Cervical Cytology Between Conventional Papanicolaou Smear and Liquid-Based Cytology (Sure Path®).
Kituncharoen S; Tantbirojn P; Niruthisard S
Asian Pac J Cancer Prev; 2015; 16(18):8491-4. PubMed ID: 26745107
[TBL] [Abstract][Full Text] [Related]
19. Has the ThinPrep method of cervical screening maintained its improvement over conventional smears in terms of specimen adequacy?
Treacy A; Reynolds J; Kay EW; Leader M; Grace A
Diagn Cytopathol; 2009 Apr; 37(4):239-40. PubMed ID: 19217033
[TBL] [Abstract][Full Text] [Related]
20. Dutch solutions for liquid-based cytology: analysis of unsatisfactory slides and HPV testing of equivocal cytology.
Boon ME; Rijkaart DC; Ouwerkerk-Noordam E; Korporaal H
Diagn Cytopathol; 2006 Sep; 34(9):644-8. PubMed ID: 16900471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
